Intraductal papillary mucinous neoplasm
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who underwent POPS for intraductal papillary mutinous neoplasm between June 1, 2018 and March 31, 2021
Exclusion criteria
Exclusion criteria: 1) Minor 2) Patients who are judged to be inappropriate for the principal investigator or coordinator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| diagnostic sensitivity | — |
Countries
Japan
Contacts
University of Toyama Third Department of Internal Medicine